Summary by Moomoo AI
On July 1, 2024, Akeso (Kangfang Biotech (Cayman) Limited) announced changes to its board of directors. Dr. Xia Yu and Dr. Zhou Yi resigned as executive director and non-executive director, respectively, and were succeeded by Dr. Zhang Peng as executive director, effective from June 30, 2024. Dr. Xia Yu and Dr. Zhou Yi confirmed that they had no disagreement with the board of directors and did not need to inform the shareholders or the Hong Kong Stock Exchange of their resignation. The board of directors thanked the two doctors for their contributions during their tenure. Dr. Zhang Peng, the newly appointed executive director, has approximately 20 years of experience in the biopharmaceutical industry, has held senior positions in multiple companies, and has won multiple awards. Dr. Zhang's term is three years and he will not receive any remuneration for serving as an executive director. The board of directors welcomes Dr. Zhang's joining.